Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (24)

2023

  1. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 167

  2. Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets

    Antioxidants and Redox Signaling, Vol. 39, Núm. 4-6, pp. 278-320

2022

  1. Cerium dioxide nanoparticles modulate antioxidant defences and change vascular response in the human saphenous vein

    Free Radical Biology and Medicine, Vol. 193, pp. 694-701

  2. Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes

    Antioxidants, Vol. 11, Núm. 11

  3. Impact of nitric oxide in liver cancer microenvironment

    Nitric Oxide - Biology and Chemistry, Vol. 128, pp. 1-11

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Micrornas and oxidative stress: An intriguing crosstalk to be exploited in the management of type 2 diabetes

    Antioxidants, Vol. 10, Núm. 5

  3. Testosterone administration increases leukocyte-endothelium interactions and inflammation in transgender men

    Fertility and Sterility, Vol. 115, Núm. 2, pp. 483-489

  4. Therapeutic implications of targeting antioxidants to mitochondria

    Mitochondrial Dysfunction and Nanotherapeutics: Aging, Diseases, and Nanotechnology-Related Strategies in Mitochondrial Medicine (Elsevier), pp. 459-475

  5. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?

    Journal of Pathology, Vol. 254, Núm. 3, pp. 216-228

2020

  1. Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells

    Cell Death and Disease, Vol. 11, Núm. 5

  2. Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer

    Redox Biology, Vol. 36

  3. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions

    Redox Biology, Vol. 34

  4. Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome

    Trends in Endocrinology and Metabolism, Vol. 31, Núm. 10, pp. 725-741

2019

  1. Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack

    Antiviral Research, Vol. 168, pp. 36-50

2018

  1. Mitochondria, the NLRP3 inflammasome, and sirtuins in type 2 diabetes: New therapeutic targets

    Antioxidants and Redox Signaling, Vol. 29, Núm. 8, pp. 749-791

2016

  1. The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 916-926

2015

  1. Mitochondrial (dys)function - A factor underlying the variability of efavirenz-induced hepatotoxicity?

    British Journal of Pharmacology, Vol. 172, Núm. 7, pp. 1713-1727

2013

  1. ER stress in human hepatic cells treated with Efavirenz: Mitochondria again

    Journal of Hepatology, Vol. 59, Núm. 4, pp. 780-789

2012

  1. In vivo molecular imaging of the GABA/benzodiazepine receptor complex in the aged rat brain

    Neurobiology of Aging, Vol. 33, Núm. 7, pp. 1457-1465